Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.41B |
| 2 |
Apple
AAPL
|
+$949M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$788M |
| 4 |
Microsoft
MSFT
|
+$654M |
| 5 |
Broadcom
AVGO
|
+$568M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.26B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$702M |
| 3 |
Tesla
TSLA
|
+$694M |
| 4 |
Micron Technology
MU
|
+$601M |
| 5 |
Strategy Inc
MSTR
|
+$512M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 93.3% |
| 2 | Technology | 1.97% |
| 3 | Financials | 0.89% |
| 4 | Consumer Discretionary | 0.83% |
| 5 | Healthcare | 0.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SCPH
11501
DELISTED
scPharmaceuticals
SCPH
| $75.3K | ﹤0.01% |
21,266
+2,500
| +13% | +$9.58K |
|
11502
CALL
System1
SST
$16.2M
| $75.2K | ﹤0.01% |
8,350
-100
| -1% | -$1.01K |
|
11503
CALL
Karyopharm Therapeutics
KPTI
$44M
| $74.9K | ﹤0.01% |
7,347
-4,873
| -40% | -$58.9K |
|
11504
Harvard Bioscience
HBIO
$36M
| $74.8K | ﹤0.01% |
+3,546
| New | +$81.4K |
|
11505
Foghorn Therapeutics
FHTX
$369M
| $74.6K | ﹤0.01% |
15,798
-23,793
| -60% | -$173K |
|
11506
Invesco Municipal Income Opportunities Trust
OIA
$290M
| $74.4K | ﹤0.01% |
+12,613
| New | +$82.3K |
|
11507
PUT
One Stop Systems
OSS
$282M
| $74.4K | ﹤0.01% |
22,200
+6,300
| +40% | +$16K |
|
|
ONTF
11508
CALL
DELISTED
ON24
ONTF
| $74.3K | ﹤0.01% |
11,500
-22,100
| -66% | -$142K |
|
11509
CALL
FingerMotion
FNGR
$10.6M
| $74.3K | ﹤0.01% |
61,900
+29,500
| +91% | +$57.1K |
|
11510
Black Diamond Therapeutics
BDTX
$130M
| $74.2K | ﹤0.01% |
+34,672
| New | +$99.4K |
|
11511
CALL
Kyverna Therapeutics
KYTX
$534M
| $74.1K | ﹤0.01% |
+19,800
| New | +$94.9K |
|
11512
PUT
Pulmonx
LUNG
$104M
| $74K | ﹤0.01% |
10,900
+100
| +0.9% | +$658 |
|
11513
Lexeo Therapeutics
LXEO
$409M
| $73.4K | ﹤0.01% |
+11,148
| New | +$87.8K |
|
11514
Journey Medical
DERM
$213M
| $73.2K | ﹤0.01% |
+18,722
| New | +$102K |
|
|
MITT
11515
PUT
TPG Mortgage Investment Trust
MITT
$212M
| $73.2K | ﹤0.01% |
11,000
-3,200
| -23% | -$22.6K |
|
11516
CALL
Latham Group
SWIM
$821M
| $73.1K | ﹤0.01% |
10,500
-800
| -7% | -$5.35K |
|
|
ORGN
11517
CALL
DELISTED
Origin Materials
ORGN
| $73K | ﹤0.01% |
1,900
-16,373
| -90% | -$622K |
|
|
GLQ
11518
Clough Global Equity Fund
GLQ
$151M
| $72.5K | ﹤0.01% |
+10,888
| New | +$74.8K |
|
|
LDTC
11519
DELISTED
LeddarTech
LDTC
| $72.5K | ﹤0.01% |
48,338
| – | – |
|
11520
CALL
GH Research
GHRS
$1.97B
| $72.1K | ﹤0.01% |
+10,300
| New | +$82.8K |
|
11521
InnovAge Holding
INNV
$1.5B
| $72.1K | ﹤0.01% |
+18,344
| New | +$95K |
|
11522
Butterfly Network
BFLY
$2.32B
| $72K | ﹤0.01% |
23,074
-66,178
| -74% | -$172K |
|
|
CMU
11523
DELISTED
MFS High Yield Municipal Trust
CMU
| $71.9K | ﹤0.01% |
+20,429
| New | +$73.3K |
|
11524
CALL
Xeris Biopharma Holdings
XERS
$1.57B
| $71.9K | ﹤0.01% |
21,200
-30,500
| -59% | -$98.1K |
|
|
MAPS
11525
CALL
DELISTED
WM TECHNOLOGY INC A
MAPS
| $71.6K | ﹤0.01% |
51,900
-245,500
| -83% | -$264K |
|
Similar funds
Jeff Yass's Q4 2024 Portfolio in Review
As of Q4 2024, Jeff Yass held 13,659 positions worth $663B, up 16% from $572B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jeff Yass's Q4 2024 filing shows 1,862 new, 5,386 increased, 4,790 reduced and 1,590 closed positions. Its largest new stake was State Street SPDR S&P 400 Mid Cap Value ETF: 1,000,000 shares worth $80.2M. The largest sale was iShares 20+ Year Treasury Bond ETF, an estimated $1.26B.
By sector, the portfolio is most concentrated in Miscellaneous at 93% of assets, down from 94% a quarter earlier, followed by Technology and Financials.
- Jeff Yass's largest Q4 2024 buy was State Street SPDR S&P 400 Mid Cap Value ETF: 1,000,000 shares worth $80.2M.
- Jeff Yass added most to Invesco QQQ Trust in Q4 2024, an estimated $1.41B increase.
- Jeff Yass's biggest Q4 2024 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $1.26B.
- Jeff Yass fully exited NextEra Energy 7.299% Corporate Units in Q4 2024, selling an estimated $112M.
- Jeff Yass's ten largest holdings make up 28% of its $663B portfolio in Q4 2024.
- Jeff Yass opened 1,862 new positions and closed 1,590 in Q4 2024.
- Jeff Yass's portfolio value rose 16% quarter-over-quarter to $663B.
Based on Susquehanna International Group's 13F filing for Q4 2024, filed 14 Feb 2025.